Local Pharmaceutical Developer is Among Best in the Country

Dallas-based Swiss American CDMO (Contract Development and Manufacturing Organization) has been named one of the top contract manufacturers in the country by MedTech Outlook. The company was the only organization in the southwest to make the list. For over 25 years, Swiss-American has developed, manufactured, and packaged skin and wound care products for customers around the world, and its products are used in prescription, over-the-counter, medical device, and personal care. “Being named one of the top 10 CDMO companies in the nation is a huge honor for our company and testament to our groundbreaking technology and processes in the marketplace,”… Full Story

Update: Will Physicians Soon be Allowed to Dispense Drugs in Texas?

Texas is just one of four states nationwide where physicians are not able to dispense medicine onsite, but a number of organizations are hoping to change that during 2019’s legislative session. A statewide coalition of employers and healthcare providers called the Texas Employers for Affordable Medications (TEAM Rx) is working to change the law and give patients the option of filling certain common prescriptions right at their doctor’s office rather than their local pharmacy. The DFW Business Group on Health, Texas Business Group on Health, Texas Academy of Family Physicians, Fort Bend County, and others make up the coalition. A… Full Story

Department of Justice Alleges Unsanitary Conditions at Dallas-Based Guardian Pharmacy

The Department of Justice filed a complaint in U.S. District Court for the Northern District of Texas alleging that JMA Partners Inc., a compounding pharmacy doing business as Dallas-based Guardian Pharmacy Services, and their owner Jack R. Munn failed to rectify unsanitary conditions at their drug-compounding facility. The District Court for the Northern District of Texas entered a consent decree of permanent injunction which will stop the defendants from “distributing adulterated, misbranded, and unapproved new drugs in violation of the federal Food, Drug, and Cosmetic Act.” The defendants were allegedly distributing misbranded and unapproved drugs without patient-specific prescriptions. The complaint says the drugs were… Full Story

Crowd-Sourced Drug Delivery Now Has Video Conferencing

Crowd-sourcing technology has made its way to the delivery of healthcare items with CourMed, a McKinney-based company that crowd-sources drivers to securely deliver prescriptions, high-end vitamins, supplements, and eyewear. Founded in 2015, CourMed’s technology now allows pharmacists, optometrists, high-end vitamin or supplement store owners to connect with patients via HIPA-compliant real-time video consultations, called CourMed CONNECT. For a homebound customer, these consultations can be especially valuable to make sure medication and supplements are taken correctly. “We are in the encouraging people business,” said co-founder Derrick L. Miles via release. “CourMed is more than an enterprise software and a crowdsourced network of… Full Story

Physician Convicted of Distributing Millions of Narcotics in “Pill Mill”

A Dallas area physician faces 20 years in federal prison for overseeing the illegal prescription of nearly a million units of narcotics. Dr. Carlos Luis Venegas was convicted of conspiracy to distribute a controlled substance at his alleged “pill mill” in federal court on Friday. “These pill mills help to perpetuate the tragic opioid crisis gripping our country,” said U.S. Attorney Nealy Cox via release. “Last year, America lost, on average, 116 people per day to opioid overdoses. We cannot allow unscrupulous conduct by physicians to add to the supply of dangerous drugs on the streets.” Trial evidence shower that Venegas supervised… Full Story

Steward, HCA, and Mayo Team Up to Bring Cheaper Generic Drugs to Patients

With the hope of driving down the cost of life-saving medicines, Dallas-based Steward Health Care helped found Civica Rx, a nonprofit drug company that focuses on generic medicines. Steward joins Mayo Clinic, HCA Healthcare and a total of 800 hospitals nationwide to form a network that will help identify quantities needed for in-demand drugs and develop medications at affordable prices. As an initial effort, Civica wants to help hospitals and healthcare systems obtain 14- generic drugs in 2019. A release says that Civica “acts in the best interest of patients who are at risk during drug shortages that are created… Full Story

FDA Approval for Drug that Targets Mutation in Multiple Cancers

The FDA approved a treatment that targets a specific fused gene that is common in several types cancer cells, shifting the treatment from focusing on a certain type of cancer or organ to fighting a common mutation in a wide range of tumors. Dr. Theodore Laetsch of UT Southwestern and Children’s Health is leading the work with this new form of precision medicine. The drug, called Larotrectinib, was found to be effective in 93 percent of patients tested at UT Southwestern’s Simmons Cancer Center. The mutation occurs when a TRK gene attaches to another gene, where the gene turns on and… Full Story

The Election is (Mostly) Decided – How It Impacts Healthcare in North Texas

It’s been a week since the election, and many may be wondering how the results will change the healthcare industry, if at all. Clearly top of mind for many, a Deloitte study said that 26 percent of voters said healthcare was their top issue and three out of four voters who responded that way voted for Democrats. We touched base with John McCracken, clinical professor of healthcare management at The University of Texas at Dallas Jindal School of Management and adjunct professor of family and community medicine at UT Southwestern Medical Center and Thaddeus Miller, associate professor in the University of… Full Story

Dealing with Prescription Drug Abuse in the Workplace

As opioid use continues to plague the country, employers are looking for ways to reduce addiction, missed work, and safety issues caused by addiction to highly addictive painkillers. Bonnie Merz is a Dallas-based Senior Claims Consultant at Holmes Murphy, and she advises employers about how to best manage risk in response to drug abuse. The healthcare industry is particularly vulnerable to this problem, as a Hazeldon Betty Ford study shows that Health Care Providers are more likely than the general public to abuse opioids. Starting in the 1840s when surgeons would abuse their own anesthesia for “ether frolics,” today 10 to 15 percent… Full Story

A Local Trial Could Lead to an Oral Diabetes Medication

A new medicine from Oramed might rid diabetes treatment of needles for the 30 million Americans who have the disease. The treatment may be a way to avoid the pain and fear that accompany injections while more efficiently delivering the medication. Nadav Kidron, the CEO of Oramed Pharmaceuticals, is leading a team who is working on this new delivery method. FDA trials in Dallas and around the country may lead to the end of using needles in the treatment of Type 2 diabetes. Oral delivery of the medication is not only less painful, but more efficient, Kidron says. It is… Full Story